Implication of human endogenous retrovirus W family envelope in hepatocellular carcinoma promotes MEK/ERK-mediated metastatic invasiveness and doxorubicin resistance.
Implication of human endogenous retrovirus W family envelope in hepatocellular carcinoma promotes MEK/ERK-mediated metastatic invasiveness and doxorubicin resistance.
复制标题
人内源性逆转录病毒 W 家族包膜在肝细胞癌中的作用促进 MEK/ERK 介导的转移侵袭性和阿霉素耐药性。
DOI:
10.1038/s41420-021-00562-5
复制
发表时间:
2021-07-08
影响因子:
7
通讯作者:
Zhu F
中科院分区:
文献类型:
--
作者:
Zhou Y;Liu L;Liu Y;Zhou P;Yan Q;Yu H;Chen X;Zhu F
Human endogenous retrovirus (HERVs), originating from exogenous retroviral infections of germ cells millions of years ago, have the potential for human diseases. Syncytin-1, an envelope protein encoded by the HERV W family, participates in the contexts of schizophrenia, multiple sclerosis, diabetes, and several types of cancers. Nevertheless, there is no report on the expression pattern and potential mechanism of Syncytin-1 in HCC. Here we found Syncytin-1 expression was up-regulated in HCC compared to adjacent non-tumorous tissues, especially in advanced HCC. Syncytin-1 was an independent risk factor to predict vascular invasion, metastasis, larger tumor size, and poor prognosis in HCC patients. Further analysis discovered that Syncytin-1 overexpression positively associated with HCC patients with serum HBsAg positive. Functional experiments in vitro and in vivo demonstrated that Syncytin-1 enhanced cell proliferation, metastasis, and tumorigenicity in HCC. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis suggested that the mitogen-activated protein kinase (MEK)/extracellular signal-regulated protein kinase (ERK) pathway was involved in HCC. Our clinical data indicated that the levels of phosphorylation MEK1/2 and ERK1/2 were increased in HCC comparing with adjacent non-tumorous tissues. It showed the linear correlation between Syncytin-1 expression and upregulated MEK1/2 and ERK1/2 phosphorylation levels in HCC. Furthermore, Syncytin-1 activated MEK/ERK pathway in HCC cells. In-depth research showed that the inflammation-activated MEK/ERK pathway was essential in Syncytin-1 promoted hepatocarcinogenesis. Syncytin-1 suppressed doxorubicin-induced apoptosis via MEK/ERK cascade. In conclusion, Syncytin-1 promoted HCC progression and doxorubicin resistance via the inflammation-activated MEK/ERK pathway. Our findings revealed that Syncytin-1 was a potential prognostic biomarker and therapeutic target for HCC.
登录
查看更多内容
影响因子:
4.6
作者:
Bai DS;Zhang C;Chen P;Jin SJ;Jiang GQ
通讯作者:
Jiang GQ
影响因子:
4
作者:
Liu, Changmin;Xu, Jiqin;Zheng, Jing
通讯作者:
Zheng, Jing
影响因子:
1.6
作者:
Liu, Cong;Liu, Lijuan;Zhu, Fan
通讯作者:
Zhu, Fan
影响因子:
25.7
作者:
Fujiwara N;Friedman SL;Goossens N;Hoshida Y
通讯作者:
Hoshida Y
影响因子:
12.8
作者:
Lee MJ;Xu DY;Li H;Yu GR;Leem SH;Chu IS;Kim IH;Kim DG
通讯作者:
Kim DG